ALFAVISION S | BRAWN BIOTECH | ALFAVISION S/ BRAWN BIOTECH |
|||
---|---|---|---|---|---|
P/E (TTM) | x | -15.1 | -6.0 | - | View Chart |
P/BV | x | 1.1 | 1.2 | 90.3% | View Chart |
Dividend Yield | % | 0.3 | 0.0 | - |
ALFAVISION S BRAWN BIOTECH |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
ALFAVISION S Mar-23 |
BRAWN BIOTECH Mar-23 |
ALFAVISION S/ BRAWN BIOTECH |
5-Yr Chart Click to enlarge
|
||
High | Rs | 42 | 23 | 182.1% | |
Low | Rs | 10 | 14 | 73.5% | |
Sales per share (Unadj.) | Rs | 18.6 | 74.1 | 25.1% | |
Earnings per share (Unadj.) | Rs | -0.7 | -2.9 | 23.7% | |
Cash flow per share (Unadj.) | Rs | -0.7 | -2.5 | 26.5% | |
Dividends per share (Unadj.) | Rs | 0.05 | 0 | - | |
Avg Dividend yield | % | 0.2 | 0 | - | |
Book value per share (Unadj.) | Rs | 13.7 | 21.0 | 65.3% | |
Shares outstanding (eoy) | m | 31.53 | 3.00 | 1,051.0% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 1.4 | 0.2 | 564.4% | |
Avg P/E ratio | x | -37.6 | -6.3 | 596.5% | |
P/CF ratio (eoy) | x | -38.4 | -7.2 | 533.5% | |
Price / Book Value ratio | x | 1.9 | 0.9 | 216.8% | |
Dividend payout | % | -7.3 | 0 | - | |
Avg Mkt Cap | Rs m | 813 | 55 | 1,487.2% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 1 | 14 | 6.9% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 586 | 222 | 263.5% | |
Other income | Rs m | 0 | 0 | 66.7% | |
Total revenues | Rs m | 586 | 222 | 263.4% | |
Gross profit | Rs m | 27 | -3 | -879.8% | |
Depreciation | Rs m | 0 | 1 | 45.0% | |
Interest | Rs m | 48 | 0 | 52,966.7% | |
Profit before tax | Rs m | -22 | -4 | 522.6% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 0 | 5 | 2.6% | |
Profit after tax | Rs m | -22 | -9 | 249.4% | |
Gross profit margin | % | 4.5 | -1.4 | -333.5% | |
Effective tax rate | % | -0.5 | -110.8 | 0.5% | |
Net profit margin | % | -3.7 | -3.9 | 94.6% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 542 | 134 | 404.1% | |
Current liabilities | Rs m | 50 | 80 | 62.7% | |
Net working cap to sales | % | 83.8 | 24.1 | 348.1% | |
Current ratio | x | 10.7 | 1.7 | 644.6% | |
Inventory Days | Days | 749 | 10 | 7,615.8% | |
Debtors Days | Days | 3,041 | 87,270 | 3.5% | |
Net fixed assets | Rs m | 1,507 | 10 | 15,503.1% | |
Share capital | Rs m | 62 | 30 | 206.4% | |
"Free" reserves | Rs m | 371 | 33 | 1,120.7% | |
Net worth | Rs m | 433 | 63 | 685.9% | |
Long term debt | Rs m | 1,565 | 0 | - | |
Total assets | Rs m | 2,048 | 144 | 1,425.4% | |
Interest coverage | x | 0.5 | -44.7 | -1.2% | |
Debt to equity ratio | x | 3.6 | 0 | - | |
Sales to assets ratio | x | 0.3 | 1.5 | 18.5% | |
Return on assets | % | 1.3 | -6.0 | -21.3% | |
Return on equity | % | -5.0 | -13.8 | 36.4% | |
Return on capital | % | 1.3 | -6.4 | -20.5% | |
Exports to sales | % | 0 | 0 | - | |
Imports to sales | % | 0 | 0 | - | |
Exports (fob) | Rs m | NA | NA | - | |
Imports (cif) | Rs m | NA | NA | - | |
Fx inflow | Rs m | 0 | 0 | - | |
Fx outflow | Rs m | 0 | 0 | - | |
Net fx | Rs m | 0 | 0 | - |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 26 | 3 | 802.5% | |
From Investments | Rs m | -160 | -1 | 16,674.0% | |
From Financial Activity | Rs m | 127 | NA | -158,475.0% | |
Net Cashflow | Rs m | -8 | 2 | -363.6% |
Indian Promoters | % | 24.8 | 53.6 | 46.2% | |
Foreign collaborators | % | 0.0 | 0.0 | - | |
Indian inst/Mut Fund | % | 0.0 | 0.4 | - | |
FIIs | % | 0.0 | 0.0 | - | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 75.2 | 46.4 | 162.2% | |
Shareholders | 2,884 | 4,160 | 69.3% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare ALFAVISION S With: ADANI ENTERPRISES REDINGTON MMTC SIRCA PAINTS INDIA NOVARTIS
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | ALFAVISION S | BRAWN PHARMA |
---|---|---|
1-Day | 2.38% | 4.99% |
1-Month | 2.74% | 18.24% |
1-Year | 16.47% | 52.80% |
3-Year CAGR | 56.22% | -6.98% |
5-Year CAGR | 34.71% | -9.70% |
* Compound Annual Growth Rate
Here are more details on the ALFAVISION S share price and the BRAWN PHARMA share price.
Moving on to shareholding structures...
The promoters of ALFAVISION S hold a 24.8% stake in the company. In case of BRAWN PHARMA the stake stands at 53.6%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of ALFAVISION S and the shareholding pattern of BRAWN PHARMA.
Finally, a word on dividends...
In the most recent financial year, ALFAVISION S paid a dividend of Rs 0.1 per share. This amounted to a Dividend Payout ratio of -7.3%.
BRAWN PHARMA paid Rs 0.0, and its dividend payout ratio stood at -0.0%.
You may visit here to review the dividend history of ALFAVISION S, and the dividend history of BRAWN PHARMA.
For a sector overview, read our finance sector report.
After opening the day on positive note, Indian share markets reversed the trend as the session progressed and ended lower.